[A multi-center study on the long-term mortality and related risk factors in patients with chronic heart failure

S Y Qi1, D M Wang, H B Yu

  • 1*Department of Cardiology, Bethune International Peace Hospital, Shijiazhuang 050082, China.

Insights

Cardiac resynchronization therapy (CRT) for chronic heart failure showed a 25.50% all-cause mortality, with higher rates in ischemic cardiomyopathy and sudden cardiac death. CRT-D significantly reduced mortality compared to CRT-P.

Area of Science:

  • Cardiology
  • Medical Technology
  • Public Health

Background:

  • Chronic heart failure (CHF) poses a significant mortality risk.
  • Cardiac resynchronization therapy (CRT) is a treatment option for select CHF patients.
  • Long-term outcomes and patient characteristics associated with CRT require ongoing analysis.

Purpose of the Study:

  • To analyze long-term mortality and patient characteristics following cardiac resynchronization therapy (CRT) in chronic heart failure patients.
  • To compare mortality rates between ischemic (ICM) and non-ischemic (NICM) cardiomyopathy.
  • To evaluate the impact of CRT-P versus CRT-D on patient survival and causes of death.

Main Methods:

  • Retrospective analysis of 200 chronic heart failure patients who received CRT between March 2001 and June 2013.
  • Inclusion of data from three medical centers.
  • Analysis of mortality, causes of death, echocardiographic parameters, and device type (CRT-P vs. CRT-D).

Main Results:

  • The all-cause mortality rate was 25.50%, with higher mortality in ICM (33.90%) than NICM (21.98%) patients.
  • Cardiac death (70.59%) was the leading cause of mortality, with sudden death accounting for 41.18%.
  • Patients receiving CRT-D had significantly lower mortality (21.57%) compared to CRT-P (78.43%), with non-cardiac death predominating in the CRT-D group.

Conclusions:

  • CRT demonstrated a 25.50% all-cause mortality in this cohort, with ICM patients experiencing higher mortality.
  • Sudden cardiac death was the primary cause of mortality.
  • CRT-D implantation was associated with significantly lower mortality rates than CRT-P, suggesting improved outcomes.

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
494
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
453
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K